Literature DB >> 21454547

Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase.

Angela Baljuls1, Regina Mahr, Inge Schwarzenau, Thomas Müller, Lisa Polzien, Mirko Hekman, Ulf R Rapp.   

Abstract

The serine/threonine kinase RAF is a central component of the MAPK cascade. Regulation of RAF activity is highly complex and involves recruitment to membranes and association with Ras and scaffold proteins as well as multiple phosphorylation and dephosphorylation events. Previously, we identified by molecular modeling an interaction between the N-region and the RKTR motif of the kinase domain in RAF and assigned a new function to this tetrapeptide segment. Here we found that a single substitution of each basic residue within the RKTR motif inhibited catalytic activity of all three RAF isoforms. However, the inhibition and phosphorylation pattern of C-RAF and A-RAF differed from B-RAF. Furthermore, substitution of the first arginine led to hyperphosphorylation and accumulation of A-RAF and C-RAF in plasma membrane fraction, indicating that this residue interferes with the recycling process of A-RAF and C-RAF but not B-RAF. In contrast, all RAF isoforms behave similarly with respect to the RKTR motif-dependent dimerization. The exchange of the second arginine led to exceedingly increased dimerization as long as one of the protomers was not mutated, suggesting that substitution of this residue with alanine may result in similar a structural rearrangement of the RAF kinase domain, as has been found for the C-RAF kinase domain co-crystallized with a dimerization-stabilizing RAF inhibitor. In summary, we provide evidence that each of the basic residues within the RKTR motif is indispensable for correct RAF function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454547      PMCID: PMC3091254          DOI: 10.1074/jbc.M110.194167

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

Authors:  Mathew J Garnett; Sareena Rana; Hugh Paterson; David Barford; Richard Marais
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

Review 2.  Raf kinases: oncogenesis and drug discovery.

Authors:  Ralf Schreck; Ulf R Rapp
Journal:  Int J Cancer       Date:  2006-11-15       Impact factor: 7.396

3.  The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.

Authors:  M Wartmann; R J Davis
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

4.  Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling.

Authors:  B Diaz; D Barnard; A Filson; S MacDonald; A King; M Marshall
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.

Authors:  Lindsey M Johnson; Kristy M James; M Dean Chamberlain; Deborah H Anderson
Journal:  Biochemistry       Date:  2005-03-08       Impact factor: 3.162

6.  Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.

Authors:  Lisa Polzien; Angela Baljuls; Ulrike E E Rennefahrt; Andreas Fischer; Werner Schmitz; Rene P Zahedi; Albert Sickmann; Renate Metz; Stefan Albert; Roland Benz; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

Review 7.  Untying the regulation of the Raf-1 kinase.

Authors:  Amardeep S Dhillon; Walter Kolch
Journal:  Arch Biochem Biophys       Date:  2002-08-01       Impact factor: 4.013

8.  Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.

Authors:  U R Rapp; M D Goldsborough; G E Mark; T I Bonner; J Groffen; F H Reynolds; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling.

Authors:  Daniel A Ritt; Daniel M Monson; Suzanne I Specht; Deborah K Morrison
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

View more
  19 in total

1.  A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency.

Authors:  Inbal Lasry; Young Ah Seo; Hadas Ityel; Nechama Shalva; Ben Pode-Shakked; Fabian Glaser; Bluma Berman; Igor Berezovsky; Alexander Goncearenco; Aharon Klar; Jacob Levy; Yair Anikster; Shannon L Kelleher; Yehuda G Assaraf
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

2.  Kinase domain dimerization drives RIPK3-dependent necroptosis.

Authors:  Saravanan Raju; Daniel M Whalen; Meron Mengistu; Carter Swanson; John G Quinn; Susan S Taylor; Joshua D Webster; Kim Newton; Andrey S Shaw
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

3.  Phosphorylation of the C-Raf N Region Promotes Raf Dimerization.

Authors:  Maho Takahashi; Yanping Li; Tara J Dillon; Yumi Kariya; Philip J S Stork
Journal:  Mol Cell Biol       Date:  2017-09-12       Impact factor: 4.272

4.  Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation.

Authors:  Shahana Mitra; Baijayanti Ghosh; Nilanjan Gayen; Joydeep Roy; Atin K Mandal
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 5.  Ras-Mediated Activation of the Raf Family Kinases.

Authors:  Elizabeth M Terrell; Deborah K Morrison
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

6.  Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling.

Authors:  Michael Röring; Ricarda Herr; Gina J Fiala; Katharina Heilmann; Sandra Braun; Anja E Eisenhardt; Sebastian Halbach; David Capper; Andreas von Deimling; Wolfgang W Schamel; Darren N Saunders; Tilman Brummer
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

7.  Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas.

Authors:  Angela J Sievert; Shih-Shan Lang; Katie L Boucher; Peter J Madsen; Erin Slaunwhite; Namrata Choudhari; Meghan Kellet; Phillip B Storm; Adam C Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

Review 8.  RAF kinase dimerization: implications for drug discovery and clinical outcomes.

Authors:  Tilman Brummer; Campbell McInnes
Journal:  Oncogene       Date:  2020-04-08       Impact factor: 9.867

9.  BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.

Authors:  Katherine E Hutchinson; Doron Lipson; Philip J Stephens; Geoff Otto; Brian D Lehmann; Pamela L Lyle; Cindy L Vnencak-Jones; Jeffrey S Ross; Jennifer A Pietenpol; Jeffrey A Sosman; Igor Puzanov; Vincent A Miller; William Pao
Journal:  Clin Cancer Res       Date:  2013-12-15       Impact factor: 12.531

10.  Allosteric activation of functionally asymmetric RAF kinase dimers.

Authors:  Jiancheng Hu; Edward C Stites; Haiyang Yu; Elizabeth A Germino; Hiruy S Meharena; Philip J S Stork; Alexandr P Kornev; Susan S Taylor; Andrey S Shaw
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.